StockData
INSMED Inc logo

INSMED Inc (INSM) stock

INSMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 8/3099% above fair value
$121.86−1.02 (-0.83%)

Close on Nov 17, 2026Market cap $26.73BP/E –Yield –

Insmed pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Insmed's pe ratio was 0.6× on Jan 31, 2011.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2011Jan 31, 20110.6×−0.0
2010Dec 31, 20100.7×–

More Insmed figures

See a number that looks wrong?